Concepedia

Author

Enrico Ricevuto

University of L'AquilaORCID

Also Known As

Antonio Russo, E RICEVUTO, E Ricevuto, E. RICEVUTO, E. Ricevuto, ENRICO RICEVUTO, Enrico Ricevuto, Enrico Roggero, Felice Giuliante, Pierluigi Cosenza

206

Publications

3.1K

Citations

28

H-Index

75

Concepts

All Affiliations

University of L'AquilaSan Salvatore HospitalSapienza University of RomeUniversity of Chieti-PescaraIstituti di Ricovero e Cura a Carattere Scientifico
ER

About

Enrico Ricevuto is an author at University of L'Aquila specializing in medicine, oncology, and pathology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

18

29

900

2

Health Sciences

3

3

111

3

Public Health

3

3

82

4

Engineering

1

1

12

5

Nursing

1

1

30

Enrico Ricevuto

×

68

Publications

2.5K

Citations

27

H-Index

YearCitations

Cardiovascular toxicity following sunitinib therapy in metastatic renal cell carcinoma: a multicenter analysis

Giuseppe Di Lorenzo, Riccardo Autorino, Gianni Bruni,

Annals of Oncology

2009

204

A Six-Gene Signature Predicting Breast Cancer Lung Metastasis

Thomas Landemaine, Amanda Jackson, Akeila Bellahcène,

Cancer Research

2008

171

Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancer

Francesco Baudi, Barbara Quaresima, Cristina Grandinetti,

Human Mutation

2001

143

Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patients

Silvio Romano, Simona Fratini, Enrico Ricevuto,

British Journal of Cancer

2011

142

Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study

B Iacopetta, Antonio Russo, Viviana Bazan,

Annals of Oncology

2006

117

Efficacy of nivolumab in pre-treated non-small-cell lung cancer patients harbouring KRAS mutations

Francesco Passiglia, Federico Cappuzzo, Oscar Alabiso,

British Journal of Cancer

2018

85

Prophylactic options in patients with 5-fluorouracil-associated cardiotoxicity

G. Cianci, Micaela Morelli, Katia Cannita,

British Journal of Cancer

2003

71

Recommendations for the implementation of BRCA testing in ovarian cancer patients and their relatives

Stefania Gori, Massimo Barberis, Maria Angela Bella,

Critical Reviews in Oncology/Hematology

2019

69

Azacitidine improves antitumor effects of docetaxel and cisplatin in aggressive prostate cancer models

Claudio Festuccia, Giovanni Luca Gravina, Anna Maria D’Alessandro,

Endocrine Related Cancer

2009

67

Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro

Claudio Festuccia, Paola Muzi, Giovanni Luca Gravina,

International Journal of Oncology

2007

66

Page 1